FDA has encouraged companies to pursue nonprescription status for opioid-reversal drugs

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

‘RuPaul’s Drag Race’ announces first trans man contestant in season 13 cast

VH1 announced on Wednesday that “RuPaul’s Drag Race” will return for Season…

‘Four beautiful kids’: Community remembers slain University of Idaho students at vigil

Fighting back tears, parents of slain University of Idaho students shared moments…

U.S. economy gains 916,000 jobs as vaccinations spur labor market recovery

The U.S. economy added 916,000 jobs last month and the unemployment rate…

Congress braces for high-stakes week over shutdown, default and infrastructure

WASHINGTON — The Democratic-controlled Congress is poised for a chaotic week. On…